United Therapeutics Corp.

ISIN US91307C1027

WKN 923818

Overview

Quote

GBP 222.90

10/04/2025 (gettex)

-3.36%

daily change

52 weeks low/high

186.39

317.57

Description

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

Show more Show less

Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals United States

Chart

09/04/2024 - 09/04/2025

Add ETF for comparison

Show more chart settings

Financials

Key metrics

Market capitalisation, EUR	11,512.68 m
EPS, EUR	22.74
P/B ratio	1.95
P/E ratio	11.35
Dividend yield	0.00%

Income statement (2024)

Revenue, EUR	2,660.08 m
Net income, EUR	1,104.84 m
Profit margin	41.53%

What ETF is United Therapeutics Corp. in?

There are 188 ETFs which contain United Therapeutics Corp.. All of these ETFs are listed in the table below. The ETF with the largest weighting of United Therapeutics Corp. is the First Trust NYSE Arca Biotechnology UCITS ETF Acc.

Show entries

Search:

ETF	Weight	Investment focus	Fund size (in m EUR)
First Trust NYSE Arca Biotechnology UCITS ETF Acc	2.86%	Equity United States Health Care Biotech	6
L&G Pharma Breakthrough UCITS ETF	2.45%	Equity World Health Care Innovation	17
WisdomTree BioRevolution UCITS ETF USD Acc	2.00%	Equity World Health Care Social/Environmental Biotech	3
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)	1.40%	Equity United States Health Care Biotech	22
iShares Nasdaq US Biotechnology UCITS ETF	1.40%	Equity United States Health Care Biotech	343
L&G Healthcare Breakthrough UCITS ETF USD Acc	1.22%	Equity World Health Care Innovation	46
Invesco Nasdaq Next Generation 100 UCITS ETF Acc	0.90%	Equity United States Technology	34
First Trust US IPO Index UCITS ETF Acc	0.58%	Equity United States IPO	7
Ossiam US ESG Low Carbon Equity Factors UCITS ETF 1A (USD)	0.52%	Equity United States Multi-Factor Strategy Climate Change	18
Ossiam US ESG Low Carbon Equity Factors UCITS ETF 1A (EUR)	0.52%	Equity United States Multi-Factor Strategy Climate Change	3

Showing 1 to 10 of 188 entries

1 2 3 4 5…19

Performance

Returns overview

YTD	-18.45%
1 month	-5.28%
3 months	-22.31%
6 months	-15.51%
1 year	+23.32%
3 years	+58.25%
5 years	+197.61%
Since inception (MAX)	+138.00%
2024	+64.17%
2023	-24.59%
2022	+42.52%
2021	+45.51%

Monthly returns in a heat map

Risk

Risk metrics in this section:

Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.

ETF returns include dividend payments (if applicable).